The significance of the ratio of serum soluble fms-like tyrosine kinase-1/placenta growth factor for predicting development of preeclampsia
Lixia Jiang
Abstract
Lixia Jiang
Abstract
Objective To detect the levels of serum soluble fms-like tyrosine kinase-1(sFlt-1) and placenta growth factor(PLGF) during the second trimester in the serum of women in normal pregnancy and women who subsequently develop preeclampsia,and investigate the role of sFlt-1/PLGF ratio as an early marker for the development of preeclampsia.Methods The serum levels of PLGF and sFlt-1 in 200 healthy pregnant women and 57 women with preeclampsia were determined by enzyme-linked immunosorbent assay(ELISA).The ratio of sFlt-1/PLGF was calculated.Results The serum sFlt-1 levels were significantly higher in the women with preeclampsia [(1 385.0±178.8)ng/L] than in healthy controls [(1 087.3±122.7)ng/L](P0.01).The PLGF levels were significantly lower in the women with preeclampsia [(501.9±86.3)ng/L] than in healthy controls [(712.7±103.6)ng/L](P0.01).In the women with preeclampsia,sFlt-1 levels were negatively correlated with PLGF(r =-0.629,P0.01),and in healthy controls,there were positively correlations between the PLGF and sFlt-1 levels(r =0.682,P0.01).In the second trimester,the ratio of sFlt-1/PLGF was 1.9,and its sensitivity and specificity were 89.5% and 97.5%.Conclusions Preeclampsia showes a strong association with increased levels of sFlt-1 and decreased levels of PLGF in the second trimester.The sFlt-1/PLGF ratio may be an early marker for the development of preeclampsia.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To detect the levels of serum soluble fms-like tyrosine kinase-1(sFlt-1) and placenta growth factor(PLGF) during the second trimester in the serum of women in normal pregnancy and women who subsequently develop preeclampsia,and investigate the role of sFlt-1/PLGF ratio as an early marker for the development of preeclampsia.Methods The serum levels of PLGF and sFlt-1 in 200 healthy pregnant women and 57 women with preeclampsia were determined by enzyme-linked immunosorbent assay(ELISA).The ratio of sFlt-1/PLGF was calculated.Results The serum sFlt-1 levels were significantly higher in the women with preeclampsia [(1 385.0±178.8)ng/L] than in healthy controls [(1 087.3±122.7)ng/L](P0.01).The PLGF levels were significantly lower in the women with preeclampsia [(501.9±86.3)ng/L] than in healthy controls [(712.7±103.6)ng/L](P0.01).In the women with preeclampsia,sFlt-1 levels were negatively correlated with PLGF(r =-0.629,P0.01),and in healthy controls,there were positively correlations between the PLGF and sFlt-1 levels(r =0.682,P0.01).In the second trimester,the ratio of sFlt-1/PLGF was 1.9,and its sensitivity and specificity were 89.5% and 97.5%.Conclusions Preeclampsia showes a strong association with increased levels of sFlt-1 and decreased levels of PLGF in the second trimester.The sFlt-1/PLGF ratio may be an early marker for the development of preeclampsia.
Key concepts: Preeclampsia, Placental growth factor, Soluble fms-like tyrosine kinase-1, Medicine, Placenta, Internal medicine, Pregnancy, Second trimester